Familial aggregation and early expression of hyperapobetalipoproteinemia.

[1]  K. Hiwada,et al.  Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. , 1984, Atherosclerosis.

[2]  J. Barboriak,et al.  Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B. , 1984, Atherosclerosis.

[3]  R. Krauss,et al.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Sniderman,et al.  Atherosclerosis and apoproteins B and A-I. , 1983, Preventive medicine.

[5]  J. Badimón,et al.  Monoclonal antibodies to human plasma low-density lipoproteins. II. Evaluation for use in radioimmunoassay for apolipoprotein B in patients with coronary artery disease. , 1983, Clinical chemistry.

[6]  A. Noma,et al.  Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. , 1983, Atherosclerosis.

[7]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[8]  A. Sniderman,et al.  Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. , 1982, Annals of internal medicine.

[9]  S. Daiger,et al.  Familial aggregation of coronary heart disease and its relation to known genetic risk factors. , 1982, The American journal of cardiology.

[10]  J. Deslypere,et al.  Discriminative value of lipids and apoproteins in coronary heart disease. , 1982, Atherosclerosis.

[11]  E. Lee,et al.  Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. , 1981, Atherosclerosis.

[12]  R. Frye,et al.  Association of Risk Factor Variables and Coronary Artery Disease Documented with Angiography , 1981, Circulation.

[13]  W. Riesen,et al.  Apoproteins and lipids as discriminators of severity of coronary heart disease. , 1980, Atherosclerosis.

[14]  W. Kimberling,et al.  Genetic–Epidemiologic Study of Early–onset Ischemic Heart Disease , 1980, Circulation.

[15]  G. Assmann,et al.  Lipoprotein and apoprotein values in coronary angiography patients. , 1980, Artery.

[16]  S. Shapiro,et al.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[18]  A. Gotto,et al.  The plasma lipoproteins: structure and metabolism. , 1978, Annual review of biochemistry.

[19]  F. Epstein.  Genetics of ischaemic heart disease. , 1976, Postgraduate medical journal.

[20]  A. Sniderman,et al.  Determination of B protein of low density lipoprotein directly in plasma. , 1975, Journal of lipid research.

[21]  R. Brand,et al.  Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. , 1975, JAMA.

[22]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[23]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.

[24]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[25]  J Slack,et al.  The Increased Risk of Death from Ischaemic Heart Disease in First Degree Relatives of 121 Men and 96 Women with Ischaemic Heart Disease , 1966, Journal of medical genetics.

[26]  C. Jenkins,et al.  Coronary heart disease in the Western collaborative group study. A follow-up experience of two years. , 1966, JAMA.